Literature DB >> 11813199

Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay.

Leonor Huerta1, Edmundo Lamoyi, Armida Báez-Saldaña, Carlos Larralde.   

Abstract

BACKGROUND: In vitro fusion of transfected cells expressing the human immunodeficiency virus (HIV) envelope proteins gp120/gp41, with target cells expressing CD4, and a suitable chemokine coreceptor is used widely to investigate the mechanisms of molecular recognition and membrane fusion involved in the entry of the HIV genome into cells and in syncytia formation.
METHODS: We developed an assay that uses two different fluorescent lipophilic probes to single label each reacting cell population and flow cytometry to quantify the extent of cellular fusion after coculture.
RESULTS: Fused cells are detected as double-fluorescent particles in this assay, therefore permitting measurement of their proportion in the total cell population. The time course and extent of HIV-glycoprotein-related cellular fusion, the optimal cell ratio, the size and cell composition of the fusion products, and the inhibition of fusion caused by soluble CD4 and anti-CXCR4 antibody 12G5 were determined. The assay was applied to measure fusion between gp120/gp41 and CD4-expressing cells growing as monolayers (HeLa/CHO fusion), as well as to suspension lymphocyte cultures (Jurkat/Jurkat fusion).
CONCLUSIONS: The method's simple technical and minimal cell-invasive procedures, as well as its non-ambiguous automatic numerical quantification should be useful for the study of factors influencing cell-cell fusion. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813199     DOI: 10.1002/cyto.10051

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  12 in total

1.  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

Authors:  Florian Steinberg; Simon D Gerber; Thorsten Rieckmann; Beat Trueb
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

2.  The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.

Authors:  Levon G Abrahamyan; Samvel R Mkrtchyan; James Binley; Min Lu; Grigory B Melikyan; Fredric S Cohen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.

Authors:  Avraham Ashkenazi; Mathias Viard; Yael Wexler-Cohen; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2011-03-23       Impact factor: 5.191

4.  Flow cytometry analysis of cell population dynamics and cell cycle during HIV-1 envelope-mediated formation of syncytia in vitro.

Authors:  Israel Torres-Castro; César N Cortés-Rubio; Guadalupe Sandoval; Edmundo Lamoyi; Carlos Larralde; Leonor Huerta
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-18       Impact factor: 2.416

5.  A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion.

Authors:  Anthony M Esposito; Alexandra Y Soare; Foramben Patel; Namita Satija; Benjamin K Chen; Talia H Swartz
Journal:  J Vis Exp       Date:  2018-08-14       Impact factor: 1.355

6.  Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion.

Authors:  Kelly Huang; Len Incognito; Xing Cheng; Nancy D Ulbrandt; Herren Wu
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

7.  Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.

Authors:  Yael Wexler-Cohen; Yechiel Shai
Journal:  PLoS Pathog       Date:  2009-07-10       Impact factor: 6.823

8.  A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.

Authors:  Anthony M Esposito; Pamela Cheung; Talia H Swartz; Hongru Li; Tshidi Tsibane; Natasha D Durham; Christopher F Basler; Dan P Felsenfeld; Benjamin K Chen
Journal:  Virology       Date:  2016-01-21       Impact factor: 3.616

9.  Bimolecular fluorescence complementation analysis of eukaryotic fusion products.

Authors:  Ho-Pi Lin; Claudius Vincenz; Kevin W Eliceiri; Tom K Kerppola; Brenda M Ogle
Journal:  Biol Cell       Date:  2010-08-06       Impact factor: 4.458

10.  Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.

Authors:  Kelly Huang; Heather Lawlor; Roderick Tang; Randall S MacGill; Nancy D Ulbrandt; Herren Wu
Journal:  Virus Genes       Date:  2010-01-29       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.